Cargando…

Parasympathetic neurogenesis is strongly associated with tumor budding and correlates with an adverse prognosis in pancreatic ductal adenocarcinoma

OBJECTIVE: To investigate the frequency of parasympathetic neurogenesis and determine its association with tumor budding and prognosis in pancreatic ductal adenocarcinoma (PDAC). METHODS: Parasympathetic neurogenesis was defined as the distribution of abnormal parasympathetic nerves in the stroma ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lingfu, Guo, Limei, Tao, Ming, Fu, Wei, Xiu, Dianrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865610/ https://www.ncbi.nlm.nih.gov/pubmed/27199515 http://dx.doi.org/10.21147/j.issn.1000-9604.2016.02.05

Ejemplares similares

G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma
por: Zhang, Lingfu, et al.
Publicado: (2018)

Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma
por: Qu, Chao, et al.
Publicado: (2022)

High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Zhang, Lingfu, et al.
Publicado: (2016)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Tao, Lianyuan, et al.
Publicado: (2016)

Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis
por: Tao, Lianyuan, et al.
Publicado: (2016)

Pancreatic duct obstruction after pancreaticojejunostomy: implications for early prediction and prevention of long-term pancreatic complications
por: Zhang, Lingfu, et al.
Publicado: (2018)

Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis
por: Li, Wendi, et al.
Publicado: (2017)

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
por: Karamitopoulou, Eva, et al.
Publicado: (2013)

Serum Derived Exosomes From Pancreatic Cancer Patients Promoted Metastasis: An iTRAQ-Based Proteomic Analysis
por: Tang, Puxian, et al.
Publicado: (2019)

Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
por: MacCurtain, Benjamin M., et al.
Publicado: (2021)

Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013)

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019)

Tumor Budding Score Is a Strong and Independent Prognostic Factor in Patients With Pancreatic Ductal Adenocarcinoma: An Evaluation of Whole Slide Pathology Images of Large Sections
por: Jiang, Hui, et al.
Publicado: (2021)

SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer
por: Aghamaliyev, Ughur, et al.
Publicado: (2023)

An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
por: Tang, Yichen, et al.
Publicado: (2014)

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

The effects of systemic inflammatory response on prognosis of pancreatic ductal adenocarcinoma
por: Aktekin, Ali, et al.
Publicado: (2019)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
por: Hayashi, Akimasa, et al.
Publicado: (2020)

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
por: Seeliger, Hendrik, et al.
Publicado: (2018)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Hang, Junjie, et al.
Publicado: (2016)

GLI1 expression in pancreatic ductal adenocarcinoma correlates the clinical significance and prognosis: A meta-analysis
por: Li, Ruidan, et al.
Publicado: (2020)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018)

PRSS1 genotype is associated with prognosis in patients with pancreatic ductal adenocarcinoma
por: Wu, Huasheng, et al.
Publicado: (2020)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
por: Yamada, Shinichiro, et al.
Publicado: (2021)

Analysis of Methylation‐driven Genes in Pancreatic Ductal Adenocarcinoma for Predicting Prognosis
por: Zhang, Zihan, et al.
Publicado: (2021)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
por: Yang, Yefan, et al.
Publicado: (2022)

The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma
por: Luan, Hong, et al.
Publicado: (2022)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
por: Zhang, Xiu‐Ping, et al.
Publicado: (2021)

Oral mycobiota and pancreatic ductal adenocarcinoma
por: Wei, Ailin, et al.
Publicado: (2022)

Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_svhmdoqtiqvv0vdk6u1u29urc3